Auspex Pharmaceuticals Lands $20,000,000 Series E Financing

  • Feed Type
  • Date
    1/8/2014
  • Company Name
    Auspex Pharmaceuticals
  • Mailing Address
    3366 North Torrey Pines Court La Jolla, CA 92037
  • Company Description
    Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
  • Website
    http://www.auspexpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series E
  • Proceeds Purposes
    These financings strengthen the balance sheet as we advance SD-809, our lead program, in Phase 3 clinical development for the treatment of chorea associated with Huntington’s disease.
  • M&A Terms
  • Venture Investor
    Deerfield Capital
  • Venture Investor
    Thomas, McNerny & Partners
  • Venture Investor
    CMEA Capital
  • Venture Investor
    Panorama Capital
  • Venture Investor
    BioMed Ventures
  • Venture Investor
    Undisclosed